Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant PMS2 antibody (AA 1-200)

This Rabbit Monoclonal antibody specifically detects PMS2 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7858658
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant PMS2 antibody (AA 1-200) (ABIN7858658)

Target

See all PMS2 Antibodies
PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))

Antibody Type

Recombinant Antibody

Reactivity

  • 83
  • 13
  • 10
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 71
  • 15
Rabbit

Clonality

  • 47
  • 39
Monoclonal

Conjugate

  • 60
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
This PMS2 antibody is un-conjugated

Application

  • 54
  • 31
  • 30
  • 25
  • 20
  • 18
  • 13
  • 11
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

PMS2-8374R
  • Binding Specificity

    • 7
    • 6
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200

    Purpose

    Recombinant PMS2 (Postmeiotic Segregation Increased 2) Antibody

    Specificity

    PMS2 is involved in DNA mismatch repair. It forms a heterodimer with MLH1 and this complex interacts with other complexes bound to mismatched bases. Defects in PMS2 are the cause of hereditary non-polyposis colorectal cancer type 4 (HNPCC4). Mutations in more than one gene locus can be involved alone or in combination in the production of the HNPCC phenotype (also called Lynch syndrome). Most families with clinically recognized HNPCC have mutations in either MLH1 or MSH2 genes. HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset colorectal carcinoma (CRC) and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world, and accounts for 15 % of all colon cancers. Defects in PMS2 are a cause of mismatch repair cancer syndrome (MMRCS), also known as Turcot syndrome or brain tumor-polyposis syndrome 1 (BTPS1). MMRCS is an autosomal dominant disorder characterized by malignant tumors of the brain associated with multiple colorectal adenomas. Skin features include sebaceous cysts, hyperpigmented and cafe au lait spots.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa1-200) of human PMS2 protein (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))

    Alternative Name

    PMS2

    Background

    DNA mismatch repair protein PMS2, hereditary non-polyposis colorectal cancer type 4 (HNPCC4), Mismatch repair gene PMSL2, PMS1 protein homolog 2, postmeiotic segregation increased 2 (S. cerevisiae), PMS2CL

    Human colon carcinoma.

    Molecular Weight

    96kDa

    Gene ID

    5395, 632637

    UniProt

    P54278

    Pathways

    DNA Damage Repair, Production of Molecular Mediator of Immune Response
You are here:
Chat with us!